A Pooled Analysis of Datopotamab Deruxtecan in Patients With EGFR-Mutated NSCLC
- Myung Ju Ahn
- , Aaron Lisberg
- , Yasushi Goto
- , Jacob Sands
- , Min Hee Hong
- , Luis Paz-Ares
- , Elvire Pons-Tostivint
- , Maurice Pérol
- , Enriqueta Felip
- , Shunichi Sugawara
- , Hidetoshi Hayashi
- , Byoung Chul Cho
- , George Blumenschein
- , Elaine Shum
- , Jong Seok Lee
- , Rebecca S. Heist
- , Robin Cornelissen
- , Wen Cheng Chang
- , Dariusz Kowalski
- , Hong Zebger-Gong
- University of California at Los Angeles
- National Cancer Center Japan
- Dana-Farber Cancer Institute
- Yonsei University
- Hospital Universitario 12 de Octubre
- Nantes University
- Centre Léon Bérard
- Autonomous University of Barcelona
- Sendai Kousei Hospital
- Kindai University
- University of Texas MD Anderson Cancer Center
- New York University
- Seoul National University
- Harvard University
- Erasmus University Rotterdam
- Chang Gung Memorial Hospital
- Maria Sklodowska-Curie Institute of Oncology
- Daiichi Sankyo Company, Limited
- Kyushu University
Research output: Contribution to journal › Article › peer-review
23
Link opens in a new tab
Scopus
citations